- Home
- FBIO vs JHI Comparison
FBIO vs JHI Comparison
Compare FBIO & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBIO | JHI |
|---|---|---|
| Founded | 2006 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.9M | 123.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FBIO | JHI |
|---|---|---|
| Price | $4.01 | $13.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 560.7K | 29.5K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | ★ $62,303,000.00 | N/A |
| Revenue This Year | $29.71 | N/A |
| Revenue Next Year | $49.34 | N/A |
| P/E Ratio | ★ N/A | $12.47 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $11.63 |
| 52 Week High | $4.20 | $13.40 |
Technical Indicators
Market Signals| Indicator | FBIO | JHI |
|---|---|---|
| Relative Strength Index (RSI) | 75.05 | 42.75 |
| Support Level | $3.54 | $13.57 |
| Resistance Level | $3.81 | $13.70 |
| Average True Range (ATR) | 0.24 | 0.09 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 94.82 | 59.99 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.